- Types of Eczema
- Eczema in Children
- Living Well
- Eczema Products
- Get Involved
- For Medical Professionals
Researchers examined the skin of children who have atopic dermatitis combined with food allergies and identified characteristics that are unique to the dual condition compared to AD alone.
The relationship between atopic dermatitis and Staphylococcus aureus is longstanding and complex. A Dutch company is investing in a new technology that targets staph to help reduce disease severity.
In addition to conjunctivitis, a widely reported side effect of the atopic dermatitis biologic Dupixent (dupilumab), researchers report that eosinophilia and facial eczema could also be side effects.
The communication pathway between the skin and the gastrointestinal tract may be complex, but it could hold the key to the relationship between AD and food allergies.
A study conducted in The Netherlands found a strong association between the severity of pediatric AD and the composition of bacteria found in both the nasal passages and on the skin.
The Swiss scientists theorized that the same immune cells that protect us against the normally harmless Malassezia fungus might also play a fundamental role in triggering atopic dermatitis.
Galderma’s nemolizumab and Dermira’s lebrikizumab are two new biologics for atopic dermatitis that are working their way toward FDA approval.
A NEA-funded study found that mothers of children with moderate to severe atopic dermatitis are more likely to experience sleep loss and caregiver fatigue.
The researchers suggest doctors combine basic skincare techniques with cutting-edge treatments to maximize the well-being of their patients.
Historically, pediatric atopic dermatitis patients have been excluded from the early stages of the drug development process, but this soon may change.